Difficulty: Medium
Average Score: 89%
Practice
Which of the following has the longest half-life of all antiarrhythmic drugs?
Correct answer
B
Rationale
The correct answer is B) Amiodarone, which has the longest half-life of all antiarrhythmic drugs. Amiodarone's extensive half-life is attributed to its unique pharmacokinetic properties, including its large volume of distribution and slow elimination rate. This extended half-life allows for once-daily dosing and steady-state plasma levels to be achieved after several weeks of treatment.
Option A) Adenosine is not the correct answer because it has an extremely short half-life of less than 10 seconds, making it unsuitable for prolonged antiarrhythmic effects.
Option C) Disopyramide has a half-life of around 6-9 hours, making it shorter than amiodarone and not the longest among the options provided.
Option D) Esmolol has a very short half-life of about 9 minutes, making it a rapidly acting but short-lived beta-blocker, which is useful in situations where quick titration or discontinuation is needed.
Understanding the half-life of drugs is crucial in clinical practice as it impacts dosing frequency, steady-state concentration attainment, and potential for drug interactions or accumulation. In the context of antiarrhythmic therapy, knowing the half-life of drugs like amiodarone can guide clinicians in optimizing dosing regimens for efficacy and safety.
Option A) Adenosine is not the correct answer because it has an extremely short half-life of less than 10 seconds, making it unsuitable for prolonged antiarrhythmic effects.
Option C) Disopyramide has a half-life of around 6-9 hours, making it shorter than amiodarone and not the longest among the options provided.
Option D) Esmolol has a very short half-life of about 9 minutes, making it a rapidly acting but short-lived beta-blocker, which is useful in situations where quick titration or discontinuation is needed.
Understanding the half-life of drugs is crucial in clinical practice as it impacts dosing frequency, steady-state concentration attainment, and potential for drug interactions or accumulation. In the context of antiarrhythmic therapy, knowing the half-life of drugs like amiodarone can guide clinicians in optimizing dosing regimens for efficacy and safety.